These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 15314893)
41. [Myelodysplastic syndromes--clinical and biological features]. Yoshida Y Gan To Kagaku Ryoho; 1994 Feb; 21(2):135-40. PubMed ID: 8311482 [TBL] [Abstract][Full Text] [Related]
46. [Aplastic anemia and myelodysplasia: a not-always-easy distinction]. Sardeo G; Gaion F; Artusi T; Dalla Pria AF; Romano G; Puglisi A Minerva Med; 1987 Oct; 78(20):1519-22. PubMed ID: 3670695 [TBL] [Abstract][Full Text] [Related]
47. Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes. Gassmann W; Schmitz N; Löffler H; De Witte T Semin Hematol; 1996 Jul; 33(3):196-205. PubMed ID: 8819230 [No Abstract] [Full Text] [Related]
48. Myelodysplastic syndromes: from morphology to molecular biology. Part I. Classification, natural history and cell biology of myelodysplasia. Yoshida Y; Stephenson J; Mufti GJ Int J Hematol; 1993 Apr; 57(2):87-97. PubMed ID: 8494998 [TBL] [Abstract][Full Text] [Related]
49. [Ferrokinetics and bone marrow scanning in patients with myelodysplastic syndrome, hypoplastic myelodysplastic syndrome and aplastic anemia]. Ohno Y; Takahashi Y; Yoshida Y Rinsho Ketsueki; 1993 Mar; 34(3):260-4. PubMed ID: 8479076 [TBL] [Abstract][Full Text] [Related]
51. [Simple refractory anemia. Response to treatment using maturative factors]. Rovira M; Feliu E; Sierra J; Boccia A; Aguilar JL; Vives-Corrons JL; Rozman C Med Clin (Barc); 1989 Nov; 93(14):546-7. PubMed ID: 2622253 [TBL] [Abstract][Full Text] [Related]
52. Significance of electron-dense deposits in the mitochondrial matrix of erythroid precursors in aplastic anaemia and myelodysplastic syndrome. Bessho F; Ohnishi H; Tabuchi K; Kobayashi M; Hayashi Y Br J Haematol; 1999 Apr; 105(1):149-54. PubMed ID: 10233378 [TBL] [Abstract][Full Text] [Related]
53. Refractory anemias, pre-leukemia and myelodysplasias. Silver RT Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(6):266-9. PubMed ID: 3836481 [No Abstract] [Full Text] [Related]
54. Myelodysplastic syndrome in two dogs. Weiss DJ; Raskin R; Zerbe C J Am Vet Med Assoc; 1985 Nov; 187(10):1038-40. PubMed ID: 4066460 [TBL] [Abstract][Full Text] [Related]
55. [Cytologic aspects and nosographic update of myelodysplastic syndromes]. Flandrin G Pathol Biol (Paris); 1997 Sep; 45(7):545-9. PubMed ID: 9404477 [TBL] [Abstract][Full Text] [Related]
57. [Indication and results of hematopoietic stem cell transplantation. 3. Aplastic anemia and myelodysplastic syndrome]. Sakamaki H Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1477-82. PubMed ID: 9780674 [No Abstract] [Full Text] [Related]
58. [Intense neutropenia of 14 years duration as the only manifestation of a myelodysplastic syndrome]. Las Heras G; Marti JM; Villamor N; Ribera JM; Feliu E; Rozman C Med Clin (Barc); 1995 Nov; 105(16):619-21. PubMed ID: 8523943 [TBL] [Abstract][Full Text] [Related]
59. Myelodysplasia: clinical and morphological aspects and treatment. Geary CG Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():138-40. PubMed ID: 2653491 [No Abstract] [Full Text] [Related]